Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective
journal contributionposted on 03.08.2015, 14:04 by James B. Rose, Michael May, David Williams
The determinants of adoption of regenerative medicine therapies are currently poorly understood. This study aims to draw comparison between the UK and Canada in terms of factors likely to affect healthcare adoption of future regenerative therapies in ophthalmology. Conducting semi-structured interviews with senior ophthalmologists in the UK and Canada, their perceptions of factors either enabling or limiting adoption were recorded and analyzed. A number of key concepts were extracted from the interview data, perceived by stakeholders to contribute to adoption. The core factors developed in this work will be of use to those looking to understand the opportunities and risks involved in securing clinician adoption in both the UK and Canada.
This work was funded by the Engineering and Physical Sciences Research Council (EPSRC) through the EPSRC Doctoral Training Centre in Regenerative Medicine.
- Mechanical, Electrical and Manufacturing Engineering